Real-time, in vivo rodent imaging, allows researchers to observe and monitor several normal and abnormal biological processes. Data collected using the eyes™ series, provides crucial initial insights and generate quantitative results that, in combination with the Visual | eyes™  interface, compose an essential platform for every preclinical laboratory.

placeholder

Oncology

Non-invasively assess your agent's targeting properties, real-time monitor drug delivery and track tumor progression.

placeholder

Infection, Inflammation

Acquire detailed insights into disease mechanisms, enhance more accurate diagnostics while supporting the development or improvement of new or already existing therapeutics.

placeholder

Protocol optimization

Test different animal preparation conditions, drug concentrations and administration routes to optimize your protocols.

placeholder

Quick insights

Scan the same mouse at multiple time points to determine the optimal moments for 3D imaging. Conduct super-fast QC to exclude faulty injected subjects from further and more complex studies.

Applications with eyes™

Planar imaging

Extending SPECT workflows with fast planar imaging

Fast whole-body planar imaging for rapid assessment of radiopharmaceutical distribution and early kinetics across a broad range of radionuclides

Image info: ⁹⁹ᵐTc-labelled GRPR-targeting peptide in a PC-3 xenograft model - 0-60 min post injection - down to 10 sec frames - 30 MBq injected activity
Study performed in collaboration with the Radiopharmaceutical Chemistry Group at INRASTES, NCSR "Demokritos" (Dr. Ioannis Pirmetttis) and NuclearPharm

Oncology

Metabolic phenotyping across tumor models using preclinical PET

Tumor model imaging using ¹⁸F-FDG

Image info: 1h post injection – 20 min scan - total injected activity 3MBq​

Bone imaging

Molecular tomography of skeletal structures

Distribution of free ¹⁸F in bone tissue

Image info: 1h post injection - injected activity 4MBq​
Study performed in BIOEMTECH Laboratories

Back to top